Cargando…
Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
Alopecia universalis (AU) is an autoimmune disorder characterized by non-scarring hair loss in the scalp, eyebrows, beard, and nearly the entire body, negatively affecting patient prognosis. Available treatments are usually unsatisfactory. The autoimmune attacks of hair follicles induced by CD8+ T c...
Autores principales: | Yu, Ling, Yu, Huiqian, Zhang, Shuai, Hao, Yanzhao, Zhang, Shoumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251371/ https://www.ncbi.nlm.nih.gov/pubmed/35795663 http://dx.doi.org/10.3389/fimmu.2022.904156 |
Ejemplares similares
-
Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
por: Anzengruber, Florian, et al.
Publicado: (2016) -
Suspected Herpes Zoster-associated Encephalitis during Treatment with Oral Tofacitinib in Alopecia Universalis
por: Hosking, Anna-Marie, et al.
Publicado: (2018) -
Clinical Experience with Oral Tofacitinib in a Patient with Alopecia Areata Universalis and Rheumatoid Arthritis
por: Abe, Daniele Tiemi, et al.
Publicado: (2020) -
Balance of tofacitinib efficacy and disease flare in the treatment of alopecia universalis: A case report and review of the literature
por: Chiang, Audris, et al.
Publicado: (2018) -
Brazilian Experience of the Treatment of Alopecia Universalis with the Novel Antirheumatic Therapy Tofacitinib: A Case Series
por: Scheinberg, Morton, et al.
Publicado: (2017)